EMA Authorised: Nexium Control (esomeprazole) — Haleon Ireland Dungarvan Limited

View source ↗

Summary

The EMA authorized Nexium Control, a product containing esomeprazole, for gastroesophageal reflux disease, with Haleon Ireland Dungarvan Limited as the marketin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Nexium Control (esomeprazole)

Snippet

Status: Authorised. Therapeutic area: Gastroesophageal Reflux. MAH: Haleon Ireland Dungarvan Limited. Decision date: 25/02/2025